OPIANT PHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Investing Activities in USD from 2011 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Opiant Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2011 to 2021.
  • Opiant Pharmaceuticals, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2022 was $12.5M.
  • Opiant Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$15M, a 29406% decline from 2020.
  • Opiant Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2020 was -$50.9K, a 83.2% increase from 2019.
  • Opiant Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2019 was -$302K.
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$15M -$15M -29406% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-15
2020 -$50.9K +$252K +83.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 -$302K -$302K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 $0 $0 Jan 1, 2018 Dec 31, 2018 10-K 2020-03-04
2017 $0 +$7.54K Aug 1, 2016 Jul 31, 2017 10-K 2017-10-13
2016 -$7.54K Aug 1, 2015 Jul 31, 2016 10-K 2017-10-13
2012 $0 $0 Aug 1, 2011 Jul 31, 2012 10-K/A 2012-11-01
2011 $0 Aug 1, 2010 Jul 31, 2011 10-K/A 2012-11-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.